medigraphic.com

2012, Number 1

<< Back

Cir Cir 2012; 80 (1)

Practice guidelines for the implementation of a quality program in thromboprophylaxis and treatment management in patients with venous thromboembolic disease

Carrillo-Esper R, Alcántar-Luna E, Herrera-Cornejo MA, Jaimovich D, Ramos-Corrales MA, Villagómez-Ortiz A

Language: Spanish
References: 28
Page: 92-105
PDF size: 647.56 Kb.


ABSTRACT

Background: Venous thromboembolic disease is a major cause of morbidity and hospital mortality worldwide. Although exact figures are unknown in Mexico, achieving uniformity of criteria among the specialties involved in the prophylaxis and treatment will offer a clearer picture and contribute to a more rational and interdisciplinary approach in order to improve the quality of care for patients and increase the level of awareness of this entity.
Discussion: For the preparation of this document, a total of 11 medical specialists from Mexico City and the interior of the country met along with a highly experienced professional from Chicago, IL, USA with wide experience in the field and knowledge of methodology for the development of a management algorithm for prophylaxis in at-risk patients of venous thromboembolic disease. The expert group met in plenary working sessions, managed uniform criteria and reached consensus agreement by issuing a series of useful recommendations for the care of patients with venous thromboembolism in Mexican hospitals.
Conclusions: In Mexico there is the need to develop and disseminate guidelines on thromboprophylaxis and treatment of venous thromboembolic disease because of the wide disparity of views or simple misinformation, leading to diagnostic and treatment behaviors unique to each institution.


REFERENCES

  1. Sigler ML, Castañeda GR, Rubio JA. Trombosis venosa profunda y embolia pulmonar. Cir Gen 2003;25:80-81.

  2. Villagómez A. Guías para el diagnóstico, prevención y tratamiento de la enfermedad tromboembólica venosa. Grupo de trabajo. Rev Mex Anestesiol 2006;29(suppl 2):S303-S334.

  3. Grendys E, Fiorica J. Advances in the prevention and treatment of deep vein thrombosis and pulmonary embolism. Curr Opin Obstet Gynecol 1999;11:71-79.

  4. Hettiarachi RJ, Lok J, Prins MH, Buller HR, Prandoni P. Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk, indicators and diagnosis. Cancer 1998;83:180-185.

  5. Villagómez A, Hernández S, Castro M, Maxil A. Tromboembolia pulmonar. Acta Med Gpo Ang 2005;3:33-39.

  6. Bottaro FJ, Elizondo MC, Doti C, Bruetman SE, Pérez PD, Bullorsky EO, et al. Efficacy of extended thrombo-prophylaxis in major abdominal surgery: what does the evidence show? A meta-analysis. Thromb Haemost 2008;99:1104-1111.

  7. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Antithrombotic and thrombolytic therapy. Prevention of Venous Thromboembolism. CHEST 8th ed. 2008;133(6S):381S-453S.

  8. Carrillo R, Zaragoza G, Mejía G, Rivera J, Moyao D, Genis MA, et al. Guía de práctica clínica basada en la evidencia para el manejo de anestesia regional y anticoagulación. Rev Mex Anestesiol 2009;32:S247-S276.

  9. Majluf A, Villagómez A, Cabrera A, García J, Carrillo R, Espinosa F, et al. Recomendaciones para el diagnóstico, prevención y tratamiento de la enfermedad troboembólica venosa. Gac Méd Méx 2007;143(S1):1-49.

  10. Ochoa FJ, Carrillo R, Escudero PM, Meillón L, Martínez R, Barroso S, et al. Parámetros de práctica clínica basados en evidencia en tromboprofilaxis: diagnóstico y tratamiento de la enfermedad tromboembólica en el paciente con cáncer. GAMO 2009;8(S4):7-27.

  11. Allen DJ, Chae-Kim SH, Trousdale DM. Risks and complications of neuraxial anesthesia and the use of anticoagulation in the surgical patient. Proc (Bayl Univ Med Cent) 2002;15:369-373.

  12. Horlocker TT, Wedel DJ, Benzon H, Brown DL, Enneking FK, Heit JA. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 2003;28:172-197.

  13. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-926.

  14. Sandoval ZJ, Martínez GM, Gómez A. Tromboembolia pulmonar aguda. PAC Cardio-1. Sociedad Mexicana de Cardiología. México City: Intersistemas, 1998. pp. 7-9.

  15. Martínez C. Diagnóstico de la Enfermedad Tromboembólica Venosa. Enfermedad tromboembólica venosa: Guía práctica. Alfil, 2007. pp. 123-129.

  16. Hoffman M, Monroe DM. Coagulation 2006: A modern view of hemostasis. Hematol Oncol Clin North Am 2007;21:1-11.

  17. Brinkhous KM. Smth HP. The inhibition of blood clotting: an unidentified substance which acts in conjunction with heparin to prevent the conversion of prothrombin into thrombin. Am J Physiol 1999;125:683-687.

  18. Pineda L, Hathwar VS, Grant BJ. Clinical suspicion of fatal pulmonary embolism. Chest 2001;120:791-795.

  19. Dalen JE. Pulmonary embolism: what have we learned since Virchow? Natural history, pathophysiology and diagnosis. Chest 2002;122:1440-1456.

  20. Douketis JD, Kearon C, Bates S, Duku EK, Ginsherg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998;279:458-462.

  21. Suárez C. Tratamiento ambulatorio de la enfermedad tromboembólica venosa. Med Clin (Barc) 2002;3(suppl 2):43-45.

  22. Hanson PO, Welin L, Tibblin G, Eriksson H Deep vein thrombosis and pulmonary embolism in the general population. Arch Intern Med 1997;157:1665-1670.

  23. Silverstein MD, Heit JA, Mohr DN, Eriksson H. Trends in the incidence of deep vein thromboses and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998;158:585-593.

  24. Heit J, Melton LJ, Lohse CM, Petterson T, Silverstein M, Mohr D, et al. Incidence of venous thromboembolism in hospitalized patients vs. community residents. Mayo Clin Proc 2001;76:1102-1110.

  25. ACC/AHA. Guidelines for the Management of Patients with STElevation Myocardial Infarction. Circulation 2004;110:588-636.

  26. ACC/AHA. Guidelines for the management of patients without STelevation coronary syndrome. Circulation 2000;102:1193.

  27. Hill J, Treasure T. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. (This guideline updates NICE clinical guideline). Heart 2010;96:879-882.

  28. NICE Clinical Guideline 92: Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. National Clinical Guideline Centre, 2010. [Disponible en:] http://www.wales.nhs.uk/sites3/Documents/781/CG92NICEGuidelinePDF.pdf




2020     |     www.medigraphic.com